Polly Murphy

Director/Board Member en CELCUITY INC. .

Fortuna: 202 112 $ al 31/03/2024

59 años

Health Technology

Consumer Services

Perfil

Polly A.
Murphy is an Independent Director at Atea Pharmaceuticals, Inc., Celcuity, Inc., and Chief Business Officer at UroGen Pharma Ltd.
She previously worked as Vice President-Commercial Development at Pfizer Inc. from 2019 to 2020 and as Senior VP-Business & Scientific Services at The Scripps Research Institute from 2005 to 2008.
Murphy holds a doctorate from Iowa State University and an MBA from Nova Southeastern University, Inc.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
CELCUITY INC. 0.02%	15/05/2023	5 000 ( 0.02% )	108 000 $	31/03/2024
ATEA PHARMACEUTICALS, INC. 0.03%	16/06/2023	23 295 ( 0.03% )	94 112 $	31/03/2024

Cargos activos de Polly Murphy

Empresas	Cargo	Inicio
UROGEN PHARMA LTD.	Corporate Officer/Principal	09/09/2020
ATEA PHARMACEUTICALS, INC.	Director/Board Member	01/08/2020
CELCUITY INC.	Director/Board Member	12/09/2022

Todos los cargos activos de Polly Murphy

Antiguos cargos conocidos de Polly Murphy.

Empresas	Cargo	Fin
PFIZER, INC.	Corporate Officer/Principal	01/08/2020
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.	Corporate Officer/Principal	01/08/2008